Skip to main content
. Author manuscript; available in PMC: 2020 Apr 15.
Published in final edited form as: Cancer Res. 2019 Sep 3;79(20):5159–5166. doi: 10.1158/0008-5472.CAN-19-0647

Figure 3. Heterozygous Atmin loss increases proliferation of lung tumor cells and tumor grafts.

Figure 3

A) Loss-of-heterozygosity testing for Atmin gene. Left, genotyping analysis of Atmin alleles in lung tumor cells and tail DNA. Right, number of genomic Atmin DNA copies, measured by Q-PCR and normalised to the 36B4 gene.

B) Graph showing the difference in cell proliferation between AtminΔL/+ KP and KP cells.

C) Graph showing the volume of xenograft tumors at the indicated timepoints after subcutaneous injection of AtminΔL/+ KP and KP cells.

D) Representative RNAScope images, showing Atmin and Ppib (positive control) mRNA in AtminΔL/+ KP- and KP-derived xenografts.